Identification of a small molecule that modifies MglA/SspA interaction and impairs intramacrophage survival of Francisella tularensis.
The transcription factors MglA and SspA of Francisella tularensis form a heterodimer complex and interact with the RNA polymerase to regulate the expression of the Francisella pathogenicity island (FPI) genes. These genes are essential for this pathogen's virulence and survival within host cells. In this study, we used a small molecule screening to identify quinacrine as a thermal stabilizing compound for F. tularensis SCHU S4 MglA and SspA. A bacterial two-hybrid system was used to analyze the in vivo effect of quinacrine on the heterodimer complex. The results show that quinacrine affects the interaction between MglA and SspA, indicated by decreased β-galactosidase activity. Further in vitro analyses, using size exclusion chromatography, indicated that quinacrine does not disrupt the heterodimer formation, however, changes in the alpha helix content were confirmed by circular dichroism. Structure-guided site-directed mutagenesis experiments indicated that quinacrine makes contact with amino acid residues Y63 in MglA, and K97 in SspA, both located in the "cleft" of the interacting surfaces. In F. tularensis subsp. novicida, quinacrine decreased the transcription of the FPI genes, iglA, iglD, pdpD and pdpA. As a consequence, the intramacrophage survival capabilities of the bacteria were affected. These results support use of the MglA/SspA interacting surface, and quinacrine's chemical scaffold, for the design of high affinity molecules that will function as therapeutics for the treatment of Tularemia.
Department of Microbiology and Cell Science, Institute of Food and Agricultural Sciences, University of Florida, Gainesville, Florida, United States of America.
Algevis P
AP
Wrench
Christopher L
CL
Gardner
Claudio F
CF
Gonzalez
Graciela L
GL
Lorca
D018829:Adhesins, Bacterial / Q000737:chemistry* / Q000378:metabolism; D001426:Bacterial Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism; D005604:Francisella tularensis / Q000737:chemistry / Q000187:drug effects / Q000235:genetics* / Q000472:pathogenicity*; D015964:Gene Expression Regulation, Bacterial / Q000187:drug effects*; D006801:Humans; D008264:Macrophages / Q000382:microbiology; D062105:Molecular Docking Simulation; D016297:Mutagenesis, Site-Directed; D055503:Protein Multimerization; D017433:Protein Structure, Secondary; D011796:Quinacrine / Q000737:chemistry* / Q000494:pharmacology; D014157:Transcription Factors / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism; D014158:Transcription, Genetic / Q000187:drug effects; D014774:Virulence; D001616:beta-Galactosidase / Q000378:metabolism
D018829:Adhesins, Bacterial; D001426:Bacterial Proteins; C082314:SspA protein, bacteria; D014157:Transcription Factors; D012321:DNA-Directed RNA Polymerases; D001616:beta-Galactosidase; D011796:Quinacrine